Gene Editing A novel pan-sarbecovirus vaccine candidate neutralizes Omicron BQ.1.1 and XBB subvariants Posted on March 16, 2023 by Editorial Staff Researchers provide evidence that a novel vaccine candidate robustly neutralized SARS-CoV-2 Omicron subvariants BQ.1.1 and XBB. Share on FacebookTweetFollow us Editorial Staff Polio cases derived from new oral vaccine reported for first time Research highlights the importance of ventilation and air filtration to reduce pathogen transmission
